IDRA - Idera Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

with an average price target of $7.34. This is a potential upside of $7.34 (0%) from yesterday's end of day stock price of $0.

Idera Pharmaceuticals's activity chart (see below) currently has 5 price targets and 4 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 41.67% with an average time for these price targets to be met of 424.33 days.

Most recent stock forecast was given by GENA WANG from BARCLAYS on 19-Mar-2021. First documented stock forecast 30-Nov-2015.

Best performing analysts who are covering IDRA - Idera Pharmaceuticals:

Robert Driscoll Gena Wang Edward Tenthoff

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

2

$-5.23 (-72.34%)

14

3 years 9 days ago

1/2 (50%)

$2.25 (23.96%)

665

Buy

1

$-6.23 (-86.17%)

5

3 years 9 days ago

3/4 (75%)

$-0.98 (-49.49%)

608

Buy

32

$24.77 (342.60%)

56

6 years 4 months 19 days ago

0/3 (0%)

$20.75 (80.16%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is IDRA (Idera Pharmaceuticals) average time for price targets to be met?

On average it took 424.33 days on average for the stock forecasts to be realized with a an average price target met ratio 41.67

Which analyst has the current highest performing score on IDRA (Idera Pharmaceuticals) with a proven track record?

ROBERT DRISCOLL

Which analyst has the current lower performing score on IDRA (Idera Pharmaceuticals) with a proven track record?

EDWARD TENTHOFF

Which analyst has the most public recommendations on IDRA (Idera Pharmaceuticals)?

Robert Driscoll works at WEDBUSH and has 11 price targets and 7 ratings on IDRA

Which analyst is the currently most bullish on IDRA (Idera Pharmaceuticals)?

Edward Tenthoff with highest potential upside - $24.77

Which analyst is the currently most reserved on IDRA (Idera Pharmaceuticals)?

Robert Driscoll with lowest potential downside - -$6.23

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?